CH636965A5 - Kuenstlicher stuhl. - Google Patents
Kuenstlicher stuhl. Download PDFInfo
- Publication number
- CH636965A5 CH636965A5 CH596078A CH596078A CH636965A5 CH 636965 A5 CH636965 A5 CH 636965A5 CH 596078 A CH596078 A CH 596078A CH 596078 A CH596078 A CH 596078A CH 636965 A5 CH636965 A5 CH 636965A5
- Authority
- CH
- Switzerland
- Prior art keywords
- blood
- stool
- chair
- weight
- test
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 38
- 238000012360 testing method Methods 0.000 description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 24
- 239000011159 matrix material Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000001514 detection method Methods 0.000 description 17
- 229920002678 cellulose Polymers 0.000 description 14
- 239000001913 cellulose Substances 0.000 description 14
- 235000010980 cellulose Nutrition 0.000 description 14
- 239000000975 dye Substances 0.000 description 14
- 239000003086 colorant Substances 0.000 description 13
- 235000013980 iron oxide Nutrition 0.000 description 13
- 229920002307 Dextran Polymers 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000314 lubricant Substances 0.000 description 10
- 239000000049 pigment Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000003755 preservative agent Substances 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000000985 reactive dye Substances 0.000 description 7
- 241000147041 Guaiacum officinale Species 0.000 description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 6
- 239000004952 Polyamide Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- 229940091561 guaiac Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 6
- 239000008108 microcrystalline cellulose Substances 0.000 description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 229920002401 polyacrylamide Polymers 0.000 description 6
- 229920002647 polyamide Polymers 0.000 description 6
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 229920003086 cellulose ether Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 5
- 235000010234 sodium benzoate Nutrition 0.000 description 5
- 239000004299 sodium benzoate Substances 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000009470 Theobroma cacao Nutrition 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000001034 iron oxide pigment Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000010199 sorbic acid Nutrition 0.000 description 3
- 239000004334 sorbic acid Substances 0.000 description 3
- 229940075582 sorbic acid Drugs 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 239000004263 Guaiac resin Substances 0.000 description 2
- 229920000932 Gum guaicum Polymers 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 229920002302 Nylon 6,6 Polymers 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical group C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000019278 guaiac resin Nutrition 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 2
- -1 methylene adipamide Chemical compound 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- CTRXDTYTAAKVSM-UHFFFAOYSA-N 3-{[ethyl({4-[(4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)(2-sulfophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene})azaniumyl]methyl}benzene-1-sulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S(O)(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 CTRXDTYTAAKVSM-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 229940105402 brillant blue Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000003836 solid-state method Methods 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000009988 textile finishing Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000003563 vegetarian diet Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19772724438 DE2724438C2 (de) | 1977-05-31 | 1977-05-31 | Künstlicher Stuhl zu diagnostischen Zwecken |
| DE2819284A DE2819284C2 (de) | 1977-05-31 | 1978-05-02 | Künstlicher Stuhl zu diagnostischen Zwecken |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH636965A5 true CH636965A5 (de) | 1983-06-30 |
Family
ID=25772079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH596078A CH636965A5 (de) | 1977-05-31 | 1978-05-31 | Kuenstlicher stuhl. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4394452A (OSRAM) |
| JP (1) | JPS5417794A (OSRAM) |
| AT (1) | AT360660B (OSRAM) |
| CA (1) | CA1119922A (OSRAM) |
| CH (1) | CH636965A5 (OSRAM) |
| DE (1) | DE2819284C2 (OSRAM) |
| FR (1) | FR2393309A1 (OSRAM) |
| GB (1) | GB1579102A (OSRAM) |
| IT (1) | IT1203184B (OSRAM) |
| SE (1) | SE443239B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3827561C1 (OSRAM) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5385844A (en) * | 1993-04-22 | 1995-01-31 | Boehringer Mannheim Corporation | Polymer containing control reagents and polymers useful in control reagents |
| AU6918294A (en) * | 1993-06-10 | 1995-01-03 | Procter & Gamble Company, The | Synthetic fecal material |
| US5890907A (en) * | 1997-01-13 | 1999-04-06 | Clifford W. Estes Company, Inc. | Educational doll |
| CN1639575A (zh) * | 2001-10-05 | 2005-07-13 | 斯特里斯公司 | 用于抗朊病毒活性的体外模型 |
| US6933152B1 (en) * | 2003-04-04 | 2005-08-23 | Nerl Diagnostics | Artificial human feces |
| JP4544201B2 (ja) * | 2006-05-26 | 2010-09-15 | パナソニック電工株式会社 | 模擬便 |
| JP4544200B2 (ja) * | 2006-05-26 | 2010-09-15 | パナソニック電工株式会社 | 模擬便 |
| US20130052624A1 (en) * | 2011-08-25 | 2013-02-28 | Miguel Saps | Tridimensional stool assessment instrument, methods, and uses thereof |
| JP5957641B2 (ja) * | 2012-08-25 | 2016-07-27 | 彰 三池 | 擬似便組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1600599A (en) * | 1926-03-29 | 1926-09-21 | Parker Maria Louisa | Model of the large intestine |
| GB432571A (en) * | 1934-01-30 | 1935-07-30 | Crosse & Blackwell Ltd | Improvements in and relating to sealing compositions for cans, jars and other containers |
| US2320098A (en) * | 1939-10-18 | 1943-05-25 | Quisling Sverre | Cosmetic coloring composition |
| US2699401A (en) * | 1949-11-17 | 1955-01-11 | Reardon Company | Texture paint |
| GB708996A (en) * | 1954-04-15 | 1954-05-12 | Miles Lab | Improvements in or relating to diagnostic compositions |
| US2925365A (en) * | 1957-11-27 | 1960-02-16 | Smith Kline French Lab | Coloring solid pharmaceutical forms and compositions therefor |
| US3427176A (en) * | 1962-11-28 | 1969-02-11 | Shikoku Chem | Three-dimensional coloring composition |
| US3933594A (en) * | 1974-08-16 | 1976-01-20 | Polaroid Corporation | Method and device for determining the concentration of a substance in a fluid |
-
1978
- 1978-05-02 DE DE2819284A patent/DE2819284C2/de not_active Expired
- 1978-05-16 AT AT351578A patent/AT360660B/de not_active IP Right Cessation
- 1978-05-24 GB GB21978/78A patent/GB1579102A/en not_active Expired
- 1978-05-30 IT IT68238/78A patent/IT1203184B/it active
- 1978-05-30 US US05/910,285 patent/US4394452A/en not_active Expired - Lifetime
- 1978-05-30 FR FR7816092A patent/FR2393309A1/fr active Granted
- 1978-05-30 SE SE7806291A patent/SE443239B/sv not_active IP Right Cessation
- 1978-05-31 JP JP6559378A patent/JPS5417794A/ja active Granted
- 1978-05-31 CA CA000304546A patent/CA1119922A/en not_active Expired
- 1978-05-31 CH CH596078A patent/CH636965A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2393309B1 (OSRAM) | 1982-12-31 |
| JPS5417794A (en) | 1979-02-09 |
| FR2393309A1 (fr) | 1978-12-29 |
| SE7806291L (sv) | 1978-12-01 |
| DE2819284A1 (de) | 1979-11-15 |
| ATA351578A (de) | 1980-06-15 |
| IT7868238A0 (it) | 1978-05-30 |
| SE443239B (sv) | 1986-02-17 |
| GB1579102A (en) | 1980-11-12 |
| JPS6236180B2 (OSRAM) | 1987-08-05 |
| US4394452A (en) | 1983-07-19 |
| AT360660B (de) | 1981-01-26 |
| IT1203184B (it) | 1989-02-15 |
| CA1119922A (en) | 1982-03-16 |
| DE2819284C2 (de) | 1985-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1598153C3 (de) | Diagnostisches Mittel zum Nach weis der Inhaltsstoffe von Korperflus sigkeiten | |
| DD157834A5 (de) | Verfahren und diagnostische mittel zum nachweis von redox-reaktionen | |
| CH639204A5 (de) | Kunststofftraeger zur durchfuehrung von analytischen oder diagnostischen untersuchungen. | |
| DE1598818A1 (de) | Trockene Indikatorzubereitung zur Bestimmung von Protein in Fluessigkeiten | |
| CH636625A5 (de) | Guajaconsaeure a, verfahren zu ihrer herstellung und diese substanz enthaltende diagnostische mittel. | |
| CH636965A5 (de) | Kuenstlicher stuhl. | |
| DD247808A3 (de) | Teststreifen zur aufnahme von blutzuckertagesprofilen und verfahren zu seiner herstellung | |
| DE2951783A1 (de) | Mittel zum eichen von geraeten zum messen der haematologischen werte von vollstaendigen blutproben und verfahren zu seiner herstellung | |
| DE1598756A1 (de) | Mittel zur Bestimmung von Harnstoff in Fluessigkeiten | |
| DE2755035A1 (de) | Praeparat und element fuer die analytische bestimmung von milchsaeure oder lactat | |
| DE2309794C3 (de) | Testreagens zur Bestimmung von Ascorbinsäure | |
| DE2835296A1 (de) | Vorrichtung zur herstellung von kontrolloesungen | |
| EP3614141A1 (de) | Stabiler urin-indikator mit langzeitdetektion | |
| DE2724438C2 (de) | Künstlicher Stuhl zu diagnostischen Zwecken | |
| DE68925457T2 (de) | Diagnoseverfahren für infektionskrankheiten sowie verfahren zum nachweis und identifizierung von mikroorganismen | |
| DE2742835A1 (de) | Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis | |
| EP0340511A1 (de) | Trägergebundenes mehrkomponentiges Nachweissystem zur kolorimetrischen Bestimmung esterolytisch oder/und proteolytisch aktiver Inhaltsstoffe von Körperflüssigkeiten | |
| Jösch et al. | Urin-Arylamidase | |
| DE3838718A1 (de) | Verfahren zum aufspueren einer krankheit, die mit einer stoffwechselabnormalitaet von l-fucose in verbindung steht | |
| DE3510992A1 (de) | Analysengeraet mit einer eine oxidase enthaltenden reagenzschicht | |
| EP0033543A1 (de) | Verfahren zur Bestimmung einer speziellen Hämoglobinspezies und Verwendung dieses Verfahrens zur Bestimmung von Diabetes | |
| EP0351790A2 (de) | Verfahren zur Bestimmung von Fructosamin | |
| DE4117619C2 (OSRAM) | ||
| DE2553587C3 (de) | Verfahren zur Bestimmung von infektiösen und immunologischen Vorgängen sowie Mittel für Blutuntersuchungen | |
| Bell | THE INTERSTITIAL GRANULES (LIPOSOMES) IN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |